The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment
Abstract
Aim: The purpose of the present study was to investigate whether total antioxidant capacity (TAC) and total oxidant status (TOS) are associated with major depressive disorder (MDD) and to evaluate the impact of antidepressant treatment on TAC and TOS in MDD. Methods: Fifty‐seven MDD patients and 40 healthy controls participated in the study. Serum TAC and TOS were measured both in patients and controls using Erel's methods. Patients were treated with antidepressant drugs for 12 weeks. The treatment course was evaluated using the Montgomery–Asberg Depression Rating Scale (MADRS) in all patients. Results: TOS and oxidative stress index (OSI) were higher (P = 0.0001 for both) and TAC was lower (P = 0.0001) in the MDD group compared with those of the controls. After 3 months of antidepressant treatment, TOS and OSI were decreased and TAC was increased compared with the pretreatment values (P = 0.0001, for all). Furthermore, there were significant positive correlations between the severity of the disease and serum TOS and OSI (r = 0.584,P = 0.0001; r = 0.636,P = 0.0001, respectively). A negative correlation was found between the severity of the disease and serum TAC (r = −0.553,P = 0.0001) at the pre‐treatment stage. Conclusion: Treatment administered for 3 months to MDD patients increases TAC while decreasing TOS and OSI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals who suffer with MDD display lower serum/plasmatic total antioxidant potentials [28, 32, 48] and reduced brain GSH levels [31] as compared to matched controls.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“TOS and OSI were higher and TAC level was lower in the MDD group compared with controls (n = 40).”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“Furthermore, the authors found a positive correlation between the severity of the disease and serum TOS and OSI (r = 0.58, and r = 0.63, resp.).”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“Also, a negative correlation was found between the severity of the disease and serum TAC (r = −0.553) at the pretreatment stage.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“After 3 months of treatment with escitalopram, 10–20 mg/day, n = 10; paroxetine, 20–40 mg/day, n = 20; or sertraline, 50–100 mg/day, n = 27, TOS and OSI were decreased and TAC was increased compared with pretreatment values [32].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
A new automated colorimetric method for measuring total oxidant status
Erel, Ö. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.08.008 · Cited by 3,747
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,634
Erel, Ö. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.015 · Cited by 2,940
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949
A novel automated method to measure total antioxidant response against potent free radical reactions
Erel, Ö. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.10.014 · Cited by 1,771
Handbook of Psychiatric Measures
Salzman, C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1343 · Cited by 1,172
Research works printed but not linked: 2
- First MB, 1997, Structured Clinical Interview for DSM‐IV Clinical Version (SCID‐I/CV)
- Corapcioglu A, 1999, Structured Clinical Interview for DSM‐IV (SCID‐IV)
Cited by
Sorted by citations
Items 101–165 of 165
Sheikholeslami, M. A., Ghafghazi, S., Pouriran, R., Mortazavi, S. E., & Parvardeh, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173821 · Cited by 12
Oxidative Stress in Depression
Gałecki, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_190 · Cited by 11
Durmaz, O., İspir, E., Baykan, H., Alışık, M., & Erel, Ö. (2017) · Journal of Ect · doi:10.1097/yct.0000000000000467 · Cited by 11
Peng, T., Lin, H.-H., Tseng, T.-L., Huang, Y.-H., Tsai, P.-Y., Lin, C., Lee, M., & Chen, S.-M. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.10.018 · Cited by 10
Relationship Between Oxidative Stress Concentration and Postpartum Depression: A Cohort Study
Alamolhoda, S. H., Kariman, N., & Mirabi, P. (2020) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.84188 · Cited by 10
Camkurt, M. A., Fındıklı, E., Tolun, F. İ., Bakacak, M., Bal, N. G., Sakallı, H., & Güneş, M. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.054 · Cited by 10
Oxidative Stress and Depression among Male Shift Workers in Shahid Tondgouyan Refinery.
Khajehnasiri, F., Akhondzadeh, S., Mortazavi, S. B., Allameh, A., Khavanin, A., & Zamanian, Z. (2014) · Europe PMC (PubMed Central) · Cited by 10
Mathew, B., Srinivasan, K., Johnson, P., Thomas, T. S., & Mandal, A. K. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_586_17 · Cited by 9
Gawlik-Kotelnicka, O., Margulska, A., Gabryelska, A., Sochal, M., Białasiewicz, P., & Strzelecki, D. (2022) · Metabolites · doi:10.3390/metabo12020152 · Cited by 8
Wagner‐Skacel, J., Haidacher, F., Wiener, M., Pahsini, K., Marinschek, S., Lahousen, T., Wonisch, W., Bengesser, S., Butler, M., Lackner, S., et al. (2022) · Antioxidants · doi:10.3390/antiox11050842 · Cited by 9
Darroudi, S., Eslamiyeh, M., Al-Fayyadh, K. K. J., Bidary, M. Z., Danesteh, S., Gouji, A. H., Darban, R. A., Esmaily, H., Ghayour‐Mobarhan, M., Moohebati, M., et al. (2023) · International Journal of Public Health · doi:10.3389/ijph.2023.1606014 · Cited by 9
Selek, S., Dalkiliç, A., Kaya, M., SAVAS, H. A., Bez, Y., Çelık, H., Erel, Ö., Kaptanoğlu, B., & Herken, H. (2011) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2011.11.001 · Cited by 8
Karaaslan, Ö., Hacımusalar, Y., Bal, C., & Ercan, M. (2019) · Medical Science and Discovery · doi:10.17546/msd.488247 · Cited by 8
Oxidative Stress in Treatment-Resistant and Refractory Depression: A Hidden Therapeutic Target?
Winczewska, Z., Cubała, W. J., Radziwiłłowicz, P., & Górska‐Ponikowska, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05715-0 · Cited by 7
Sangsefidi, Z. S., Hosseinzadeh, M., Lorzadeh, E., Sangsefidi, Z. S., Salehi‐Abargouei, A., & Mirzaei, M. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2153430 · Cited by 7
Kamrani, F., Kachouei, A. A., Fereydouni, N., Tanbakuchi, D., Esmaily, H., Moohebati, M., Mahaki, H., Rezaee, A., Darroudi, S., Ghayour‐Mobarhan, M., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.172 · Cited by 8
A Paper-Based Assay for the Determination of Total Antioxidant Capacity in Human Serum Samples
Tran, M. T., Gomez, S. V., Alenicheva, V., & Remcho, V. T. (2024) · Biosensors · doi:10.3390/bios14110559 · Cited by 7
Winczewska, Z., Mechlińska, A., Radziwiłłowicz, P., Konieczna, L., Drżeżdzon, J., Jacewicz, D., Wiglusz, M., Bączek, T., Cubała, W., & Górska-Ponikowska, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103547 · Cited by 5
Evaluation of oxidant, antioxidant, and S100B levels in patients with conversion disorder
Büyükaslan, H., Kandemir, S. B., Aşoğlu, M., Kaya, H., Gokdemir, M. T. M. T., Karababa, F., Güngörmez, F., Kılıçaslan, F., & Şavik, E. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s109174 · Cited by 7
Effect of electroconvulsive therapy on the oxidative metabolism in major depressive disorder
Şahin, Ş. K., Aybastı, Ö., Elboğa, G., & Altındağ, A. (2017) · Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi) · doi:10.17826/cutf.323838 · Cited by 7
Gupta, R., Ghosh, R., Bhatia, M. S., Tripathi, A., & Gupta, L. K. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-006 · Cited by 6
Association of oxidative stress with the pathophysiology of depresion and bipolar disorder
Lačković, M., Rovčanin, B., Pantović-Stefanović, M., Ivković, M., Petronijević, N., & Damjanović, A. (2013) · Archives of Biological Sciences · doi:10.2298/abs1301369l · Cited by 6
Rahe, C., & Berger, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_17 · Cited by 6
Childhood depression and oxidative stress
Miniksar, D. Y., & Göçmen, A. Y. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00518-1 · Cited by 7
He, H., Li, P., Huang, H., Zeng, Y., Zhang, M., Chen, Z., Huang, S., Zeng, F., & Ge, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1517744 · Cited by 5
Is Riparin III a promising drug in the treatment for depression?
Mallmann, A. S. V., Chaves, R. D. C., de Oliveira, N. F., Oliveira, I. C. M., Capibaribe, V. C. C., Valentim, J. T., da Silva, D. M. A., Sartori, D. P., Rodrigues, G. C., Filho, A. J. M. C., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105824 · Cited by 5
Cheng, X., Liu, F., Zhang, X. C., Liu, Y., Guo, J., Zhong, X., Tian, D., Pei, A., Xiang, X., Yao, Y.-X., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07414-x · Cited by 4
Sarkar, A., Saha, M., Das, A. R., Banerjee, A., Majumder, R., & Bandyopadhyay, D. (2022) · ChemistrySelect · doi:10.1002/slct.202203959 · Cited by 4
Autoantibodies, Oxidative Stress, and Nutritional State in Anorexia Nervosa
Amerio, A., Martino, E., Strangio, A., Aguglia, A., Escelsior, A., Conio, B., Sukkar, S. G., & Saverino, D. (2024) · Antibodies · doi:10.3390/antib14010001 · Cited by 4
Pinto, B., Domingues, I., Ferreira, H. B., Melo, T., & Domingues, M. R. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.08.003 · Cited by 4
Tariq, U., Butt, M. S., Pasha, I., & Faisal, M. N. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01291-z · Cited by 4
Wang, D., Feng, J., Yuan, G.-Y., Yang, Y., Liu, Y., & Yang, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.6128 · Cited by 4
Azimzadeh, K., Jafarpour, H., & Adldoost, S. (2017) · Pharmaceutical and Biomedical Research · doi:10.29252/pbr.3.3.17 · Cited by 4
Potential Involvement of Mitochondrial Dysfunction in Major Depressive Disorder: Recent Evidence
Kambe, Y. (2015) · Archives of Depression and Anxiety · doi:10.17352/2455-5460.000004 · Cited by 3
Mashhadi, N. S., Khoshhali, M., Heidari‐Beni, M., & Kelishadi, R. (2022) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmac112 · Cited by 3
Depression and Oxidative Stress Interaction in Stable Coronary Heart Disease
Ivaščenko, T., Voicehovskis, V., Kalējs, O., Voicehovska, J., Šķesters, A., Pahomova, N., & Lejnieks, A. (2022) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2022-0028 · Cited by 3
Mitochondrial dysfunction and affective disorders: Focus on diet, exercise, and aging
Allen, J., Kalynchuk, L. E., & Caruncho, H. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00017-6 · Cited by 3
Oxidative stress, depression, and risk of recurrence of stable coronary heart disease
Ivaščenko, T., Voicehovskis, V., Voicehovska, J., Šķesters, A., Apsīte, K., Grigorjeva, J., Ķīvīte‐Urtāne, A., Pahomova, N., & Kalējs, O. (2021) · Cor et Vasa · doi:10.33678/cor.2021.046 · Cited by 3
Özkorumak Karagüzel, E., Civil Arslan, F., Demir, S., Saglam Aykut, D., Demirtaş, Y., & Karahan, S. C. (2022) · Journal of Clinical Psychiatry · doi:10.5505/kpd.2022.37431 · Cited by 2
Self-citationLi, T., Tan, L., & Tang, X. (2023) · PubMed Central · doi:10.12182/20230360505 · Cited by 3
Aksu, F., Kavaklı, A., Kuloğlu, T., Yılmaz, S., Kaya, E., Akkoç, R. F., Yılmaz, M., Emre, E., & Ögetürk, M. (2024) · Cureus · doi:10.7759/cureus.54914 · Cited by 2
Prolidase activity in major depressive disorder
Demir, S., İbiloğlu, A. O., Güneş, M., Bulut, M., Atlı, A., Kaya, M., Kaplan, İ., & Sır, A. (2015) · Journal of Clinical and Experimental Investigations · doi:10.5799/ahinjs.01.2015.03.0536 · Cited by 2
Self-citationTHE ROLE OF OXIDATIVE STRESS IN THE ETIOPATHOGENESIS OF DEPRESSION
Komsiyska, D., & Petkov, Y. (2019) · Trakia Journal of Sciences · doi:10.15547/tjs.2019.01.013 · Cited by 2
Botelho, M. E. M., Carlessi, A. S., Manosso, L. M., Borba, L. A., de Moura, A. B., Maciel, L. R., Andrade, N. M., Martinello, N. S., Generoso, C. M., Bencke, C. V., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-650713/v1 · Cited by 2
Petimani, M. S., Adake, P., & Aditya, A. (2019) · International Journal of Biochemistry and Biophysics · doi:10.13189/ijbb.2019.070101 · Cited by 2
Shi, X., Liu, H.-Q., Cai, S., Shen, Y.-H., Chai, J.-L., Zhang, M., Xu, C. J., Zhang, Z.-Q., Marshall, J., & Cao, C. (2026) · Science Signaling · doi:10.1126/scisignal.aec8898 · Cited by 1
Thioredoxin as an antioxidant protein as a marker in depression
Aydın, E. P., & Uyar, E. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00024-4 · Cited by 1
Arora, A., Vacy, K., Marques, C., Degeratu, M.-O., Mastropasqua, F., Humphrey, J., Ye, X., Oksanen, M., the Barwon Infant Study Investigator Group, Vuillermin, P., et al. (2025) · medRxiv · doi:10.1101/2025.05.30.25328657 · Cited by 1
Cryostimulation as Adjunct Treatment in Psychiatric Disorders
Miller, E. D. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_29
Pinto, R. B. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Oxidative Stress in Depression 103
Gaøecki, P. (2014)
Diabetes and Depression: A Bidirectional Phenomenon
Modak, S., Ghosh, M., Chakraborty, M., Chutia, D., & Bhuyan, N. R. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v70i02.005
Surana, A. R., Kumbhare, M. R., & Narkhede, H. I. (2023) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1188
Samimi, N., Eghbal, B., Hekmat, A. S., Kouhpayeh, S. A., Ghanbariasad, A., Javanmardi, K., Farjam, M., & Fakhraei, B. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i.2218
Zabihiyeganeh, M., Afshar, S. V., Kadijani, A. A., Janbozorgi, M., Akbari, A., Yahyazadeh, H., Kadijani, B. A., & Mirzaei, A. (2024) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-139852
Taghvimi, S., Kesmati, M., Tabatabaei, S. R. F., & Shahriari, A. (2023) · Jundishapur Journal of Physiology. · doi:10.32592/jjp.2.2.58
Uzun, A. D., Çakır, B., Sapmaz, Ş. Y., Bılaç, Ö., Taneli, F., & Kandemır, H. (2024) · Psychopathology · doi:10.1159/000539695
Winczewska, Z., Mechlińska, A., Konieczna, L., Drzeżdżon, J., Jacewicz, D., Wiglusz, M. S., Bączek, T., Cubała, W. J., & Górska‐Ponikowska, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5119359
Mohammadi, Y., Taebi, R., Bahreini, E., Babaei, M., & Hosseini, A. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70810
Arora, A., Vacy, K., Marques, C., Degeratu, M.-O., Mastropasqua, F., Humphrey, J., Ye, X., Oksanen, M., Vuillermin, P., Ponsonby, A., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106291 · Cited by 1
Potential of Saliva in Stroke Patients: A Review
Forszt, D., Gerreth, K., Bielas, M., & Maciejczyk, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156871
The Evaluation of Oxidative Stress and Depresion Levels in Patients with Inactive Behcet's Disease
Gül, I. G., Cumurcu, B. E., Cumurcu, T., & Eryılmaz, G. (2014) · Advances in life sciences
Self-citation
Metadata
- Authors
- Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R.
- Venue
- Psychiatry and Clinical Neurosciences
- Publisher
- Wiley
- Published
- 2009-09-23
- Volume
- 63
- Issue
- 5
- Pages
- 639-645
- ISSN
- 1323-1316 (ISSN-L)
- 1440-1819
- OpenAlex
- W1540420232
- Cited by
- 165
- References
- 29
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 13 · 2022: 12 · 2021: 11 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 9 · 2016: 10 · 2015: 12 · 2014: 13 · 2013: 9 · 2012: 12
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatry and Clinical Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, total antioxidant capacity, total oxidant status, oxidative stress, antidepressant treatment, oxidative stress index, depression severity, serum antioxidants
- MeSH terms
- Adult, Major Depressive Disorder, Female, Humans, Male, Oxidation-Reduction, Severity of Illness Index, Time Factors, Case-Control Studies, Oxidants, Selective Serotonin Reuptake Inhibitors, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
